Home | Business News | Browse by Publication | P | PR Newswire

Terumo Europe N.V. Enrolls First Patient in Clinical Trial of Nobori(TM) Drug-eluting Coronary Stent.

Publication: PR Newswire
Publication Date: 27-MAY-05
Format: Online
Delivery: Immediate Online Access

Article Excerpt
PARIS, May 27 /PRNewswire/ -- Terumo Europe N.V., Interventional Systems, an affiliate of Terumo Corporation announced today the enrollment of the first patient in the NOBORI 1 drug-eluting coronary stent clinical trial.

NOBORI 1 is a prospective, randomized clinical trial that will enroll 360 patients in 30 centres in Europe, Australia and Asia. The NOBORI 1 is an equivalency study that will compare Terumo's Nobori Biolimus A9(TM) drug- eluting stent to Boston Scientific's Taxus(TM) Express2(TM) drug-eluting stent in an un-proportional 2:1 design. The primary endpoint is 9-month in-stent late loss. Secondary endpoints include: angiographic binary restenosis, target...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from PR Newswire
Adtegrity.com Reports First Quarter Results., May 27, 2005
Twice This Week Governor Ignores Michigan Law and Turns Back on Job Pr..., May 27, 2005
Usurf Sets Earnings Release Date and Conference Call., May 27, 2005
DexOnline.com Again Rated Top Internet Yellow Pages / Local Search Sit..., May 27, 2005
As Summer 'Trauma Season' Begins, New Data From the Centers for Diseas..., May 27, 2005

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.